IVIM Health vs. Mochi Health: prices, fine print, and the honest verdict

Tirzepatide pricing

On tirzepatide, IVIM Health is the cheaper program at $278 a month all-in versus Mochi Health's $278 — a gap of $0 a month, $0 a year, at the 10 mg maintenance basis. IVIM Health: $278 a month all-in at the 10 mg maintenance basis, dose-scaled from a $208 entry, including the mandatory $75/mo membership. Mochi Health: $278 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, including the mandatory $79/mo membership.

Semaglutide pricing

On semaglutide, Mochi Health wins at $178 versus $224 all-in — $46/mo apart. IVIM Health: Semaglutide runs $224 a month all-in at the standing rate ($149 on intro/plan terms). Mochi Health: Semaglutide runs $178 a month all-in.

Transparency

IVIM Health: Source-verified (verified 2026-08-05); dispensing pharmacy not publicly named. Mochi Health: Source-verified (verified 2026-08-05); names its pharmacy — company-owned compounding facility. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

IVIM Health: membership mandatory for duration; membership mandatory; $75/mo membership recurs until cancelled. Mochi Health: membership recurs monthly; cancel membership any time; recurs until cancelled; $79/mo membership recurs until cancelled.

The gap, compounded over time

Here is what the $0 monthly spread between these two actually buys back over a treatment course — one month, $0; six months, $0; a year, $0; two years of maintenance, $0. Every figure is the all-in maintenance basis; the arithmetic reruns from the dataset.

The 24-month ledger

Maintenance therapies deserve maintenance math: over two years at standing rates, IVIM Health bills $6,672 and Mochi Health $6,672, a spread of $0 for the same molecule at the same 10 mg basis. Reference rails for the same 24 months: $5,160 at the verified floor, $10,776 on brand Zepbound at maintenance, $8,376 on Wegovy flat.

Two ladders, side by side

Put both dose ladders on the same axis and the structures argue for themselves: IVIM Health scales $208 → ~$278 by 10 mg (titration lands between $832 and $1,112); Mochi Health holds $278 on every rung (four-month titration: exactly $1,112). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.

Three buyers, two invoices

The month-one starter pays $208 at IVIM Health versus $278 at Mochi Health for the 2.5 mg rung — an early edge that reverses once the ladder climbs. The settled 10 mg maintainer — the buyer our basis is built for — pays $3,336/year at IVIM Health against $3,336 at the other: $0 of annual daylight for the same molecule and dose.

The semaglutide board

Mochi Health takes the semaglutide board too at $178 versus $224 all-in — a $46/month, $552/year spread. Both sit against a verified field floor of $133 and Wegovy's flat $349 brand rate; dual-molecule pricing also sets each program's internal switch cost when a plateau raises the tirzepatide question.

The five normalizations, applied to this pair

1 · All-in, not advertised. IVIM Health's ranked figure is $278 ($203 medication + $75 mandatory membership); Mochi Health's ranked figure is $278 ($199 medication + $79 mandatory membership). 2 · Maintenance basis. IVIM Health scales from $208 to $278, and the 10 mg figure is the one ranked; Mochi Health is dose-flat, so its entry and 10 mg figures coincide. 3 · Terms separated. IVIM Health: standing $278, no prepaid tier; Mochi Health: standing $278, no prepaid tier — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. IVIM Health: source-verified, read 2026-08-05; Mochi Health: source-verified, read 2026-08-05. 5 · Pharmacy weighed. IVIM Health names no pharmacy; Mochi Health names company-owned compounding facility — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

IVIM Health: a mandatory $75/mo membership folded into our all-in figure; membership mandatory; commitment: membership mandatory for duration. Mochi Health: a mandatory $79/mo membership folded into our all-in figure; cancel membership any time; recurs until cancelled; commitment: membership recurs monthly. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

IVIM Health carries source-verified pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Mochi Health carries source-verified pricing (last read 2026-08-05); pharmacy disclosure is its strong suit — company-owned compounding facility, owned facility. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Moving from IVIM Health to Mochi Health (or back) is administratively unglamorous: complete the new program's intake, let its prescriber issue a fresh prescription to its pharmacy, and cancel the old subscription in writing — prescriptions don't transfer between telehealth programs, and neither do prepaid balances, which is the quiet reason month-to-month terms are worth their premium.

Refills, shipping, and the week-to-week reality

The unglamorous layer — how the medication actually reaches you and stays on schedule — splits like this: IVIM Health: shipping included; consultation video visit included in membership; video visit model. Mochi Health: shipping included; consultation video visits included in membership; video visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick IVIM Health if its published terms happen to fit your state, format, or timing. Pick Mochi Health if the semaglutide line is cheaper here; you want a price that survives titration; a named pharmacy is non-negotiable for you; unlimited included clinician and dietitian visits matter more than the last $60. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

If neither one fits

The dataset's bench is deep; the closest verified third options to this matchup's price band are Found at $289 (flat, no membership); ShedRx at $289 (dose-scaled, no membership); Yucca Health at $258 (flat, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The brand benchmark both must beat

Neither program exists in a vacuum: FDA-approved Zepbound sits at $449/month at maintenance (LillyDirect or retail KwikPens, ~$350 on TrumpRx, ~$50 for newly eligible Medicare patients), and Wegovy at a flat $349. The cheaper of these two compounded options saves $2,052/year against the Zepbound benchmark — the number that has to justify accepting a not-FDA-reviewed product, per the full trade analysis. When a compounded quote drifts above ~$350, this benchmark starts winning the argument on its own.

The verdict

On the numbers alone, Mochi Health is the cheaper tirzepatide program by $0/mo and it doesn't trade that price for opacity. Both records, with dates and sources, live in the pricing database.